George Rieveschl, Inventor of Benadryl, Dies
CINCINNATIUniversity of Cincinnati (UC) alumnus and engineering professor emeritus George Rieveschl, PhD, known for inventing Benadryl, the worlds first effective antihistamine, died today at Christ Hospital, Cincinnati. He was 91.
A long-time supporter of the
Dr. Rieveschl was also the founding chairman of the University Foundation Board of Trustees.
Rieveschl was a chemistry professor at UC when he invented Benadryl.
He found to this surprise that a two-part compound he was originally testing to improve muscle-relaxing medications dramatically blocked histamine, the naturally released chemical that narrows air passages in the lungs and causes inflammation.
This breakthrough led, in 1946, to Benadryls becoming the first FDA-approved prescription antihistamine. First produced by Parke, Davis and Company, the drug is now distributed over-the-counter by the Parke-Davis division of Pfizer.
A 1937 alumnus of UC, Dr. Rieveschl spent 26 years working in the chemical industry as both a scientist and a consultant before returning to UC in 1970.
He is survived by his wife, Ellen, and two sons.
George Rieveschl, PhD
Jane Henney, MD, presents Benadryl inventor George Rieveschl, PhD, with a city proclamation noting May 16 as "60 Years of Benadryl" day.
Related Stories
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.
$15 million bequest supports endowed chair at UC College of Medicine
May 19, 2026
As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.
UC finds integrating substance use disorder treatment into clinic-based internal medicine expands access to care
May 18, 2026
A University of Cincinnati primary care teaching clinic integrates substance use disorder treatment into resident training, expanding access to addiction care and boosting physician confidence.